Literature DB >> 19605874

Routine OGTT screening for CFRD - no thanks.

Martin Walshaw1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19605874      PMCID： PMC2711864          DOI： 10.1258/jrsm.2009.s19009

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  20 in total

1.  Clinical improvement in cystic fibrosis with early insulin treatment.

Authors:  L Dobson; A T Hattersley; S Tiley; S Elworthy; P J Oades; C D Sheldon
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

Review 2.  Best practice in primary care pathology: review 3.

Authors:  W S A Smellie; J Forth; D Bareford; P Twomey; M J Galloway; E C M Logan; S R S Smart; T M Reynolds; C Waine
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Cystic fibrosis mortality and survival in the UK: 1947-2003.

Authors:  J A Dodge; P A Lewis; M Stanton; J Wilsher
Journal:  Eur Respir J       Date:  2006-12-20       Impact factor: 16.671

4.  Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline.

Authors:  C E Milla; W J Warwick; A Moran
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

5.  European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations.

Authors:  C Koch; H Cuppens; M Rainisio; U Madessani; H Harms; M Hodson; G Mastella; J Navarro; B Strandvik; S McKenzie
Journal:  Pediatr Pulmonol       Date:  2001-01

Review 6.  Diabetes mellitus in cystic fibrosis.

Authors:  D S Hardin; A Moran
Journal:  Endocrinol Metab Clin North Am       Date:  1999-12       Impact factor: 4.741

Review 7.  The association of nephrolithiasis with cystic fibrosis.

Authors:  Eric M Gibney; David S Goldfarb
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

Review 8.  Glucose intolerance in cystic fibrosis patients.

Authors:  S Lanng
Journal:  Paediatr Respir Rev       Date:  2001-09       Impact factor: 2.726

9.  Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.

Authors:  Kamlesh Mohan; Helen Miller; Hassan Burhan; Martin J Ledson; Martin J Walshaw
Journal:  Pediatr Pulmonol       Date:  2008-07

10.  A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.

Authors:  K L Nash; M E Allison; D McKeon; D J Lomas; C S Haworth; D Bilton; Graeme J M Alexander
Journal:  J Cyst Fibros       Date:  2007-11-26       Impact factor: 5.482
View more
  3 in total

1.  Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.

Authors:  Christine L Chan; Timothy Vigers; Laura Pyle; Philip S Zeitler; Scott D Sagel; Kristen J Nadeau
Journal:  J Cyst Fibros       Date:  2018-03-23       Impact factor: 5.482

Review 2.  Cystic fibrosis related diabetes.

Authors:  Donal O'Shea; Jean O'Connell
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

3.  Not performing an OGTT results in underdiagnosis, inadequate risk assessment and probable cost increases of (pre)diabetes in Han Chinese over 40 years: a population-based prospective cohort study.

Authors:  Xiang Hu; Qiao Zhang; Tian-Shu Zeng; Jiao-Yue Zhang; Jie Min; Sheng-Hua Tian; Hantao Huang; Miaomiao Peng; Nan Zhang; Mengjiao Li; Qing Wan; Fei Xiao; Yan Chen; Chaodong Wu; Lu-Lu Chen
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.